Good Days: Myelodysplastic Syndrome (MDS)

Funded
About
The Good Days: Myelodysplastic Syndrome (MDS) program provides financial assistance for patients diagnosed with MDS seeking prescribed medications like Gleevec, Revlimid, Vidaza, Dacogen, Decitabine, Azacitidine, Imatinib, Inqovi, Onureg, Lenalidomide, and Imkeldi. The program ensures that eligible patients with valid insurance receive support for treatment costs, enhancing access to essential FDA-approved drugs.
Insurance requirements: Commercially insured, Medicare / Medicaid, Underinsured
Enrollment Forms
Enrollment Form
Benefits
•$2000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Completed applications may be submitted online, via mail (Good Days Attn: Enrollment 2611 Internet Blvd, Suite 105, Frisco, TX 75034), or fax (2145703621)
•A copy of insurance cards is required. Once the application is received, patients can call 8779687233 to check on the status. If patient qualifies and funding is available, financial assistance will be provided from the date of funding approval through the remainder of the calendar year or upon exhaustion of funding
•Patients approved during the first three quarters of the year (JanuarySeptember) must reapply to be considered for funding in the next calendar year. Patients that are approved during the last quarter of the year (OctoberDecember) do not have to reapply and will be automatically enrolled for funding in the next calendar year. Enrollment for the following calendar year does not guarantee funding availability. New copies of household income documentation are required for each new enrollment
•Call 8779687233, MondayFriday, 8:00am5:00pm CST, for assistance or additional information